Svelte Medical Systems (New Providence, NJ) announced that it had successfully completed enrollment in its DIRECT II drug-eluting stent clinical study. The trial is designed to study the safety and efficacy of the company’s ...
Tags: Svelte Medical, Enrollment, DIRECT II
Svelte Medical Systems has treated the first patient in the ACES (Acrobat Coronary stent system effectiveness European Study) clinical trial. ACES is a randomized, controlled study to show the clinical benefit and utilization of the ...
Tags: Svelte Medical Systems, clinical trial, ACES, company news
Svelte Medical Systems has treated the first patient in a randomized, controlled study using its fixed-wire based system, designed for treating patients with coronary artery lesions. The low profile Svelte Acrobat Integrated Delivery ...
Tags: Svelte Medical Systems, fixed wire based system, coronary artery lesions
Svelte Medical Systems has commenced First Assessment of the Acrobat Stenting Technique European Post-Market Registry (FAASTER) study. The multi-center registry study, which will enroll up to 1,500 patients, is designed to evaluate the ...
Tags: Svelte Medical Systems, FAASTER, FAASTER study, registry study